loading
Schlusskurs vom Vortag:
$1.45
Offen:
$1.55
24-Stunden-Volumen:
14.19M
Relative Volume:
0.99
Marktkapitalisierung:
$98.89M
Einnahmen:
$1.20M
Nettoeinkommen (Verlust:
$-52.41M
KGV:
-2.2699
EPS:
-0.91
Netto-Cashflow:
$-31.25M
1W Leistung:
+15.38%
1M Leistung:
+320.17%
6M Leistung:
+89.19%
1J Leistung:
-8.30%
1-Tages-Spanne:
Value
$1.535
$2.15
1-Wochen-Bereich:
Value
$1.42
$2.17
52-Wochen-Spanne:
Value
$0.387
$3.87

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
Firmenname
Rani Therapeutics Holdings Inc
Name
Telefon
(408) 457-3700
Name
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Name
Mitarbeiter
106
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
RANI's Discussions on Twitter

Vergleichen Sie RANI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
2.0998 141.43M 1.20M -52.41M -31.25M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.25 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
649.59 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.28 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
807.96 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
187.25 41.29B 398.11M -1.03B -868.57M -5.7032

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-02 Eingeleitet Oppenheimer Outperform
2024-06-14 Eingeleitet Maxim Group Buy
2024-06-13 Eingeleitet Rodman & Renshaw Buy
2023-04-17 Fortgesetzt BTIG Research Buy
2022-10-11 Eingeleitet UBS Buy
2022-07-27 Eingeleitet H.C. Wainwright Buy
2022-06-13 Eingeleitet Wedbush Outperform
Alle ansehen

Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten

pulisher
05:37 AM

Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com

05:37 AM
pulisher
04:58 AM

Multi asset correlation models including Rani Therapeutics Holdings Inc.2025 Stock Rankings & Low Drawdown Momentum Ideas - newser.com

04:58 AM
pulisher
04:40 AM

Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com

04:40 AM
pulisher
04:38 AM

Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthIPO Watch & Safe Capital Preservation Plans - newser.com

04:38 AM
pulisher
01:41 AM

Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025Short Setup & Real-Time Volume Analysis Alerts - newser.com

01:41 AM
pulisher
01:15 AM

Institutional scanner results for Rani Therapeutics Holdings Inc.July 2025 Setups & Verified Momentum Stock Watchlist - newser.com

01:15 AM
pulisher
Oct 30, 2025

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Rani (Nasdaq: RANI) to present RT-116 bioequivalence data in dogs at ObesityWeek 2025 - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Short interest data insights for Rani Therapeutics Holdings Inc.Stop Loss & Intraday High Probability Setup Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can momentum traders help lift Rani Therapeutics Holdings Inc.Earnings Performance Report & Weekly Sector Rotation Insights - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineOptions Play & AI Powered Market Entry Strategies - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Rani Therapeutics (NASDAQ:RANI) Director Mir Imran Buys 2,083,334 Shares - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone - Markets Mojo

Oct 28, 2025
pulisher
Oct 28, 2025

Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Israel Englander, Ken Griffin, Michael Burry, Warren Buffett, ExodusPoint Capital, Rani Therapeutics Holdings Inc (RANI), Coca-Cola Co (KO), and More - Insider Monkey

Oct 28, 2025
pulisher
Oct 28, 2025

Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Will Rani Therapeutics Holdings Inc. bounce back from current supportMarket Activity Report & Weekly Breakout Stock Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis tools2025 Macro Impact & Daily Volume Surge Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics director Imran Mir a buys $1.26 million in stock - Investing.com Philippines

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics director Imran Mir a buys $1.26 million in stock By Investing.com - Investing.com South Africa

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114 - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics appoints new directors and closes private placement By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics appoints new directors and closes private placement - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics Announces Board Changes - TradingView

Oct 27, 2025

Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Rani Therapeutics Holdings Inc-Aktie (RANI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
South Cone Investments Limited
10% Owner
Oct 21 '25
Sale
2.77
4,000,000
11,074,000
2,379,194
South Cone Investments Limited
10% Owner
Oct 20 '25
Sale
2.41
1,923,000
4,637,314
6,379,194
McKinley Kate
Chief Business Officer
Dec 13 '24
Buy
1.67
17,960
29,993
17,960
Imran Talat
Chief Executive Officer
Dec 09 '24
Buy
1.94
10,296
19,974
494,751
$37.35
price up icon 1.12%
$28.35
price down icon 1.06%
$93.39
price up icon 0.86%
$103.14
price down icon 1.33%
biotechnology ONC
$308.33
price up icon 0.25%
$187.56
price down icon 3.50%
Kapitalisierung:     |  Volumen (24h):